We report that a tetramethylrhodamine-labeled dimer of the cell-penetrating peptide tAt, dftAt, penetrates live cells by escaping from endosomes with high efficiency. By mediating endosomal leakage, dftAt also delivers proteins into cultured cells after a simple co-incubation procedure. We achieved cytosolic delivery in several cell lines and primary cells and observed that only a relatively small amount of material remained trapped inside endosomes. delivery did not require a binding interaction between dftAt and a protein, multiple molecules could be delivered simultaneously, and delivery could be repeated. dftAt-mediated delivery did not noticeably affect cell viability, cell proliferation or gene expression. dftAt-based intracellular delivery should be useful for cell-based assays, cellular imaging applications and the ex vivo manipulation of cells.
We report that a tetramethylrhodamine-labeled dimer of the cell-penetrating peptide tAt, dftAt, penetrates live cells by escaping from endosomes with high efficiency. By mediating endosomal leakage, dftAt also delivers proteins into cultured cells after a simple co-incubation procedure. We achieved cytosolic delivery in several cell lines and primary cells and observed that only a relatively small amount of material remained trapped inside endosomes. delivery did not require a binding interaction between dftAt and a protein, multiple molecules could be delivered simultaneously, and delivery could be repeated. dftAt-mediated delivery did not noticeably affect cell viability, cell proliferation or gene expression. dftAt-based intracellular delivery should be useful for cell-based assays, cellular imaging applications and the ex vivo manipulation of cells.
Protein transduction strategies are extremely useful for the investigation and manipulation of cellular processes. Proteins labeled with fluorophores or stable isotopes and delivered into live cells can, for instance, be used for imaging applications or in cellulo structure determination by NMR, respectively 1, 2 .
Despite the unique opportunities provided by protein transduction technologies, current protocols are often suboptimal 3, 4 . Proteins fused to a protein transduction domain (PTD) typically use the endocytic pathway as a route of cellular entry 5 . However, the majority of PTD-protein fusions endocytosed by cells typically remain trapped inside endosomes; as a result, the amount of protein that reaches the cytosol of cells is low, and the biological outcomes achieved are poor 6 . A possible solution to this problem is to increase the ability of proteins to escape from the endocytic pathway. This is possible with membrane-destabilizing agents that disrupt endosomes [7] [8] [9] , but to date, the efficiencies of available reagents have remained low 10, 11 .
Ideally, a delivery strategy should combine efficient endosomal escape, low cell toxicity and convenience. We aimed to develop an innocuous endosomolytic agent that efficiently delivers protein cargos into cells. Our working hypothesis was that a dimeric TAT labeled with the fluorophore tetramethylrhodamine (TMR), which we call dfTAT for dimeric, fluorescent TAT, might have
Protein delivery into live cells by incubation with an endosomolytic agent
Alfredo Erazo-Oliveras 1,2 , Kristina Najjar 1,2 , Laila Dayani 1 , Ting-Yi Wang 1 , Gregory A Johnson 1 & Jean-Philippe Pellois 1 enhanced endosomolytic activity compared to that of TAT alone. We show that dfTAT efficiently delivers proteins into live cells in ~1 h without affecting cell viability or proliferation.
results dftAt penetrates the cytosol of live cells efficiently
We used TAT as the template for our design of a dimeric delivery vehicle. We introduced a lysine modified with TMR for fluorescence imaging and added a cysteine at the N terminus of TAT to permit dimerization by disulfide bond formation ( Supplementary  Fig. 1 ). Disulfide bonds are relatively stable inside endosomes but are cleaved following endosomal escape and upon entry into the reducing cytosol 3, 12, 13 . The fluorescent peptide CK(ε-NH-TMR)-TAT (fTAT) was purified as a reduced monomer. Incubation in oxygenated medium and oxidation of the free cysteine thiol of fTAT generated the dimer (CK(ε-NH-TMR)TAT) 2 (dfTAT; Supplementary Fig. 1c) . Alternatively, the thiol of CK(ε-NH-TMR)TAT was acetamidated to obtain a peptide (acfTAT) that cannot dimerize or was reacted with bis(maleimido)ethane to obtain a nonreducible dimer (nrdfTAT; Supplementary Fig. 2) .
We incubated fTAT, acfTAT, dfTAT and nrdfTAT for 1 h with HeLa cells, the mouse neuroblastoma cell line Neuro-2a and human primary dermal fibroblasts (HDFs). Internalization was first assessed by fluorescence microscopy. acfTAT (1-20 µM) localized in a punctate distribution consistent with accumulation of the peptide inside endosomes 14 (Fig. 1a) . The fluorescence signal of dfTAT was also punctate below 2 µM but became distributed in the cytosol and nucleus of an increasing number of cells at higher concentrations ( Fig. 1b and Supplementary  Fig. 3 ). The overall amount of dfTAT inside cells (in the cytosol and endosomes) also increased with the concentration of dfTAT administered extracellularly ( Fig. 1c) . We delivered dfTAT into the cytosol and nucleus of additional cell lines and primary intestinal porcine epithelial cells ( Supplementary Fig. 4 ). In all cases, cells were not stained with Sytox blue (Life Technologies), indicating that their plasma membrane was not compromised and that the cells imaged were alive.
Similarly to acfTAT, fTAT was localized inside endosomes at up to 10 µM. However, at 20 µM, many cells displayed cytosolic fluorescence, indicating that fTAT reproduced some of the activity of dfTAT by possibly dimerizing in situ ( Supplementary  Fig. 5 ). Finally, nrdfTAT displayed a cytosolic distribution similar to that obtained with dfTAT ( Supplementary Fig. 2e ), indicating that the disulfide bond present in dfTAT was not required for cytosolic penetration.
dftAt penetrates cells in a two-step process
To test whether endosomal escape is involved in delivery of dfTAT, we assessed the effects of molecules that influence endocytosis [15] [16] [17] [18] . Whereas filipin and chlorpromazine (inhibitors of caveolae-and clathrin-mediated endocytosis) had little effect, amiloride (inhibitor of macropinocytosis) and bafilomycin (V-ATPase inhibitor) inhibited the delivery of dfTAT, suggesting that macropinocytosis and endosomal acidification are important for cytosolic penetration ( Fig. 2a) . To assess whether endosomal escape could be visualized, dfTAT was incubated with cells for 5 min to permit endocytic uptake; cells were washed and then imaged in a pulse-chase experiment. dfTAT was initially localized in a punctate distribution consistent with that of endosomes (100× objective, data not shown). Yet, an increasing number of cells displayed a cytosolic distribution at later time intervals. When imaged with a 20× objective, cells with a cytosolic distribution were brighter than cells with a punctate distribution (this is consistent with TMR being partially self-quenched when dfTAT is trapped inside endosomes; Supplementary Fig. 3 ), and this was used to quantify dfTAT's cytosolic penetration as a function of time ( Fig. 2b) . Consistent with the notion that dfTAT penetrates the cytosol after endocytic uptake, the percentage of cells with cytosolic fluorescence increased from 4.3% to 76.9% over a period of 40 min.
To further test whether dfTAT escapes from endocytic organelles, we incubated cells first with DEAC-K9, a fluorescent peptide ( Supplementary Fig. 6 ) that accumulates inside endosomes 19 . After washing, cells were incubated with dfTAT. Although only a punctate distribution of fluorescence was observed with cells incubated with DEAC-K9 alone, subsequent addition of dfTAT led to a bafilomycin-dependent redistribution of the DEAC-K9 signal throughout the cytosol and nucleus (Fig. 2c) . These data indicate that dfTAT accumulates inside endosomes already containing DEAC-K9 and that dfTAT endosomal escape is also accompanied by the leakage of luminal DEAC-K9.
dftAt-mediated endosomal leakage is efficient
When endocytosed at similar levels, dfTAT escaped endosomes, whereas acfTAT did not, indicating that dfTAT is greatly more endosomolytic than acfTAT and is active inside endosomes as a dimer rather than as a reduced monomer ( Supplementary Fig. 7) . However, the cytosolic fluorescence of dfTAT possibly obscures the signal that remains inside endosomes. Under such a scenario, dfTAT endosomal escape would appear more dramatic than it really is. To establish more precisely the efficiency with which dfTAT mediates endosomal leakage, we co-incubated dfTAT with Snap-Surface 488 (New England Biolabs), a cell-impermeable green fluorophore that can react with the Snap protein fusion tag 20 . The experiment was performed in cells expressing a Snap-H2B histone construct so that Snap-Surface 488 would label the nucleus of cells upon delivery, deplete the cytosolic signal and reveal the amount of probe remaining trapped inside endosomes. Cells incubated with dfTAT and Snap-Surface 488 displayed a nuclear staining ( Fig. 2d) , whereas cells incubated with Snap-Surface 488 alone did not ( Supplementary Fig. 8 ). Cells with a brightly labeled nucleus also contained only a few dim endosomes. Analysis of the fluorescence signal indicated that 50-90% of the fluorophore escaped endosomes.
dftAt-mediated delivery is not deleterious to cells
By inducing efficient endosomal leakage, dfTAT might negatively affect cell physiology. In addition, endosomal leakage has been previously observed in cells undergoing apoptosis 21 . Endosomal leakage could therefore be either a cause or a consequence of cell death. To address these issues, we treated HeLa, MCH58, HDF and Neuro-2a cells with dfTAT for 1 h and established viability 1 and 24 h after incubation using a Sytox green exclusion assay ( Supplementary Fig. 9 ). Viability was >95% after treating cells with 5 µM dfTAT for 1 h-conditions required to achieve cytosolic distribution of dfTAT in >80% of cells. Cell morphology was also unaffected by dfTAT incubation ( Supplementary  Fig. 10 ). Likewise, dfTAT incubation did not affect the proliferation rates of HDF, HeLa or Neuro-2a cells (Fig. 3a) , and cells containing a cytosolic fluorescence signal indicative of efficient dfTAT endosomal escape were observed to divide normally by microscopy ( Fig. 3b) .
To characterize the physiological impact of dfTAT cytosolic penetration in greater detail, we performed transcriptome analysis on HDF cells incubated for 1 h in nrL-15 medium with or without 5 µM dfTAT. Cells harvested immediately after dfTAT incubation showed 11 transcripts up-or downregulated more than twofold compared to those of untreated cells (twofold is used as a significance threshold; 47,321 total transcripts detected; Fig. 3c ). Only two transcripts were dysregulated in cells incubated in DMEM for an additional 1 h and 24 h after treatment with dfTAT ( Fig. 3c and Supplementary  Fig. 11 ). Together, these results indicate that dfTAT has a minimal impact on mRNA expression and that cells recover rapidly from dfTAT-mediated endosomal leakage (corroborated by quantitative proteomic profile experiments; Supplementary Fig. 12 ).
If dfTAT perturbs many endosomes during a delivery step, we envisioned that endocytic trafficking might be a cellular process likely to be negatively affected following peptide incubation. In particular, we reasoned that dfTAT could cause endosomal leakage after an initial treatment but fail to be endocytosed or remain trapped inside damaged endocytic organelles after a second dfTAT incubation. We therefore tested the stepwise delivery of two different molecules (DEAC-K9 and Snap-Surface 488). Cells were first incubated with dfTAT (5 µM) and DEAC-K9 (5 µM) for 1 h. As expected, this incubation resulted in the cytosolic distribution of both dfTAT and DEAC-K9 (data not shown). Twenty minutes later, cells were incubated with dfTAT (5 µM) and Snap-Surface 488 (5 µM) for 1 h. Cells treated with this two-step protocol displayed cytosolic and nuclear fluorescence of both DEAC-K9 and Snap-Surface 488 ( Fig. 3d and Supplementary  Fig. 13 ). Delivery of Snap-Surface 488 did not occur in the absence of dfTAT (Supplementary Fig. 8 ) and was inhibited by bafilomycin, consistent with the notion that the second delivery step is also mediated by the endosomolytic activity of dfTAT. Moreover, the fluorescence of Snap-Surface 488 examined was comparable npg to that observed when Snap-Surface 488 was delivered into untreated cells (one-step delivery) or simultaneously with DEAC-K9 ( Supplementary Fig. 14) . Together these results establish that dfTAT-mediated delivery can be repeated. This suggests that the endocytic route employed by dfTAT is not dramatically compromised after dfTAT-mediated endosomal leakage.
dftAt delivers proteins by simple co-incubation
To determine whether dfTAT could deliver large proteins into the cytosol of cells, we chose EGFP (26 kDa) as a model. Cells were incubated with EGFP and dfTAT for 1 h and examined by microscopy. EGFP was distributed into the cytosol and nucleus in more than 90% of cells without observable toxicity ( Fig. 4a and Supplementary Fig. 15 ). To estimate how much fluorescent and folded protein was delivered, cells were counted, harvested and lysed. The lysate was analyzed by PAGE, and the fluorescence of EGFP was quantified. On the basis of this analysis, approximately 34 µM and 23 µM of EGFP was present per HDF and Neuro-2a cell, respectively ( Supplementary Fig. 16 ). As imaging confirmed that a large fraction of EGFP escaped endosomes ( Fig. 4a) , one can expect micromolar concentrations of proteins to be delivered in the cytosol of cells. To determine whether dfTAT needs to interact with a particular protein in order to successfully deliver it, we characterized the binding of dfTAT to EGFP. No fluorescence resonance energy transfer (FRET) between dfTAT and EGFP could be detected under conditions used for cellular incubation assays (Supplementary Fig. 17) . Similarly, no interaction between dfTAT and EGFP could be detected by native gel electrophoresis (Supplementary Fig. 18) . In contrast, dfTAT and BSA were found to interact in this assay (presumably through electrostatic interactions). Interestingly, addition of BSA (or fetal bovine serum or heparin) to cell incubation medium reduced the cytosolic penetration of dfTAT in a concentration-dependent manner (Supplementary Fig. 19) .
To further confirm that functional proteins can penetrate cells upon incubation with dfTAT, we tested delivery of Cre recombinase. In this assay, Cre induces recombination of a loxP-STOP-loxP sequence upstream of the EGFP-encoding gene of a reporter plasmid 22 . Therefore, cells transfected with the reporter plasmid express EGFP when Cre recombinase penetrates cells and excises the STOP signal sequence. Cells treated with TAT-Cre (1 µM) and dfTAT (5 µM) expressed EGFP (Fig. 4b) , but the percentage of EGFP + cells was greater in the presence of dfTAT (47%) than in the presence of fTAT or when TAT-Cre was incubated alone (<5%).
We also delivered FITC-anti-ATP5A, a fluorescently labeled antibody that recognizes the α-subunit of the mitochondrial ATP synthase. Cells treated with FITC-anti-ATP5A (20 µg/ml) and dfTAT (5 µM) contained green fluorescent tubular structures (Fig. 4c) . Colocalization with the blue fluorescent mitochondrial marker pTagCFP-mito confirmed that these structures were mitochondria (Supplementary Fig. 20a ). Cells treated with FITC-anti-IgG, an antibody that does not target mitochondria, did not stain tubular structures (Supplementary Fig. 20b) . These experiments confirmed that dfTAT can deliver a functional antibody into live cells.
The transcription factor HOXB4 can penetrate cells, activate transcription and induce hematopoietic stem cell expansion, either by itself or when fused to TAT [23] [24] [25] . We were therefore interested in determining whether dfTAT, by promoting cytosolic delivery, would enhance the transcriptional activity of this protein. NIH 3T3 cells were transfected with a vector containing the luciferase gene under a HOXB4-inducible promoter and with a β-galactosidase reporter as internal control. Cells were incubated with HOXB4 or TAT-HOXB4, in the absence or presence of dfTAT, for 1.5 h. We assessed the expression of luciferase by measuring the luminescence of cell lysates (normalized to β-galactosidase activity, luciferase induction represents a ratio of treated versus untreated cells). HOXB4 and TAT-HOXB4 (200 nM) alone induced a 2.2-and 5.0-fold increase in luciferase activity, respectively (Fig. 5a) . In contrast, addition of dfTAT (3 µM) led to 53.1-and 307.4-fold luciferase induction, respectively. Neither dfTAT alone nor dfTAT incubated with TAT-mCherry led to the induction of luciferase, indicating that luciferase expression was dependent on the presence of HOXB4.
Although increasing the transcriptional output of HOXB4 is valuable, precisely controlling the level and activity of HOXB4 inside cells is important to achieve desirable biological outcomes 26 . Because dfTAT appears to act independently of the molecules used for co-incubation in our assays, we hypothesized that it might be possible to titrate the amount of protein that penetrate cells by varying the protein concentration in the medium while keeping dfTAT concentration constant. Under this scenario, the efficiency of endosomal escape should remain unaffected, but the amount of material released from endosomes should change. Initial experiments with DEAC-K9 showed that the amount of fluorescent peptide delivered inside cells could be titrated using this protocol ( Fig. 5b and Supplementary Fig. 21) . Consistent with these results, luciferase induction was proportional to the concentration of HOXB4 in the medium (Fig. 5c) .
discussion
By mediating endosomal leakage, dfTAT is remarkably efficient at delivering proteins and peptides into the cytosol of cells. Delivery is efficient because the amount of material that reaches the cytosol is substantial and the amount trapped inside endosomes is relatively low, and because cytosolic delivery occurs in most cells present in a sample. Endosomal escape appears to take place in most cells once dfTAT, which is intrinsically more endosomolytic than monomeric TAT, reaches a threshold concentration within endosomes. Future studies aimed at establishing the roles played by the two copies of the peptide TAT and of the fluorophore TMR, as well as their respective arrangement, should provide more npg molecular details about the activity of dfTAT. Establishing where dfTAT escapes from the endocytic pathway should also provide valuable insights regarding its endosomolytic activity. Notably, the membrane of endosomes can be lysed by fluorescently labeled cell-penetrating peptides upon light irradiation 19, 27 . dfTAT trapped inside endosomes (for example, after incubation at 2 µM) can indeed leak out of endosomes when TMR is continuously excited for several seconds (data not shown). Yet, all delivery experiments reported herein were performed in a dark room with a dim red light. The excitation of dfTAT, when required for fluorescence microscopy, was also minimized to less than 300 ms in all images shown. Overall, we conclude that the endosomal leakage mediated by dfTAT is light independent. A remarkable aspect of dfTAT-mediated delivery is the minimal cellular responses associated with the efficient endosomal leakage observed. This is surprising because endosomal lysis can be extremely toxic by causing the rapid release of calcium into the cytosol of cells 28 . In addition, the leakage of endolysosomal proteases could contribute to toxicity. Yet, we observed that cells were not only viable but also healthy. These results are presumably valid for only the 1-h dfTAT incubation used in our assays. Continuous endosomal leakage induced by particulate wear debris induces inflammatory responses and apoptosis 29 . dfTAT could therefore promote similar effects if administered to cells for long incubation times. Notably, membrane repair mechanisms have also been shown to mask the effect of debris-induced endosomal leakage 29 . This, in turn, could also explain why dfTAT-mediated delivery is relatively innocuous under the conditions tested.
dfTAT delivers cell-impermeable molecules displaying diverse structures and properties. DEAC-K9, like dfTAT, is highly positively charged, and the isoelectric points (pI) of Cre (9.4), and HOXB4 (9.8) are also not suggestive of favorable electrostatic interactions with dfTAT. EGFP, a protein with a lower pI (6.2), does not appreciably interact with dfTAT in vitro. It is therefore likely that dfTAT does not need to interact with a given protein outside the cell or within the lumen of endosomes to achieve cytosolic delivery of that protein. Instead, interactions that occur between dfTAT and a protein with low pI such as BSA are inhibitory. Similar inhibitory effects between arginine-rich cell-penetrating peptides and negatively charged species have been observed 30, 31 .
The co-incubation protocol used herein allows several cargos to be delivered simultaneously. Alternatively, delivery can be performed in successive steps, without complex sample preparations and, as exemplified by the delivery of Snap-Surface 488 or FITC-anti-ATP5A, is ideally suited for imaging applications. In addition, co-incubation provides the opportunity to titrate the extracellular concentration of target molecules independently of dfTAT. The amount of protein delivered to the cytosol and the biological output achieved can in turn be modulated. Although our approach is likely not optimal for in vivo delivery of biologics, it could offer several advantages over existing reagents for delivery to tissue cultures and the ex vivo manipulation of cells.
methods
Methods and any associated references are available in the online version of the paper.
Accession codes. NCBI Gene Expression Omnibus: GSE57427
Note: Any Supplementary Information and Source Data files are available in the online version of the paper.
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This article was supported by awards R01GM087227 and R01GM087981 from the US National Institute of General Medical Sciences, by the Norman Ackerman Advanced Research Program and by the Robert A. Welch foundation (grant A-1769). We are grateful to M. Lasagna for technical assistance with FRET assay as well as to R. Chapkin for access to the luminometer and flow cytometer in his laboratory. We thank L. Dangott for help with proteomic analysis; C. Cepko (Harvard Medical School) for pCALNL-GFP; K. Rajewsky (Max Delbrück Center for Molecular Medicine) for pTriEx-HTNC; G. Sauvageau (Montreal University) for pTAT-HA-HOXB4; P. Zandstra (University of Toronto) for the HOXB4 luciferase reporter, engineered 3T3 cells and β-gal vectors; and I.R. Correa (New England Biolabs) for pSNAP-H2B and Snap-Surface 488. We also thank R. Burghardt online methods Peptides design, synthesis and purification. All peptides were synthesized in-house on the rink amide MBHA resin (Novabiochem) by solid-phase peptide synthesis (SPPS) using standard Fmoc protocols. Fmoc-Lys(Mtt)-OH, Fmoc-Lys(Boc)-OH, Fmoc-Gly-OH, Fmoc-Arg(Pbf)-OH, Fmoc-Gln(Trt)-OH and Fmoc-Cys(Trt)-OH (Novabiochem) were used to assemble the peptides. Reactions were carried out in a SPPS vessel at room temperature using a stream of dry N 2 to provide agitation. Fmoc deprotection was performed by addition of piperidine in dimethylformamide (DMF) (Fisher) (20%, 10 ml) to the Fmoc-peptide resin (0.30 mmol). Deprotection reactions were carried out once for 5 min (1 × 5 min) and 1 × 15 min with a washing step in between reactions. Amino acid coupling reactions were carried out for 4 h with a mixture of Fmoc-amino acid (1.2 mmol), HBTU (Novabiochem) (0.44 g, 1.1 mmol) and di-isopropylethylamine (DIEA) (Sigma) (0.51 ml, 3.0 mmol) in DMF. Upon completion of the reactions, the resin was washed with DMF and dichloromethane (DCM) (Fisher). For DEAC-K9, the DEAC fluorophore (AnaSpec) was coupled to the N terminus of the peptide after coupling of the ninth Fmoc-Lys(Boc)-OH using a mixture of DEAC, HBTU and DIEA (4, 3.9 and 10 molar equivalents (eq) with respect to the peptide) in DMF. The reaction was carried out overnight using a stream of dry N 2 to provide agitation. For CK(ε-NH-TMR)TATG (fTAT), the Mtt protecting group at the ε-amino group of Lys on CK(ε-NH-Mtt)TATG was cleaved with 2% trifluoroacetic acid (TFA) (Fisher) and 2% tri-isopropylsilane (TIS) (Sigma) in DCM, and the resin was washed with DCM and DMF. A mixture of TMR, HBTU and DIEA (4, 3.9 and 10 eq with respect to the peptide) in DMF was added to the resin, and the reaction was carried out overnight using dry N 2 to provide agitation. Following Fmoc-deprotection and peptide assembly, the resin was washed with DCM and dried in vacuo. The resin was then treated with TFA containing 2.5% H 2 O, 2.5% TIS and 2.5% ethanedithiol (EDT) (Sigma) for 3 h at room temperature to achieve global deprotection and cleavage from the resin. The crude peptide products were precipitated and washed with cold anhydrous Et 2 O (Fisher). The precipitates were resuspended in water and lyophilized. The products obtained were then resuspended in 0.1% aqueous TFA/acetonitrile. The peptides were analyzed and purified by reverse-phase HPLC. HPLC analysis was performed on a Hewlett-Packard 1200 series instrument and an analytical Vydac C18 column (5-µm particle size, 4 mm × 150 mm). The flow rate was 1 ml/min, and detection was at 214 nm and 550 nm. Semi-preparative HPLC was performed on a Vydac C18 10 × 250-mm column. The flow rate was 4 ml/min, and detection was at 214 nm and 550 nm. All runs used linear gradients of 0.1% aqueous TFA (solvent A) and 90% acetonitrile, 9.9% water and 0.1% TFA (solvent B). The correct identity of the peptides was confirmed by MALDI-TOF performed with a Shimadzu/Kratos instrument (AXIMA-CFR). fTAT expected mass was 2,041.17; observed mass was 2,040.66. DEAC-K9 expected mass, 1,412.97; observed mass, 1,415.59.
Synthesis of acetamidated C(S-CH 2 CONH 2 )K(-NH-TMR)TATG (acf TAT)
. C(S-CH 2 CONH 2 )K(ε-NH-TMR)TATG was formed after addition of iodoacetamide (Sigma) (0.275 mg, 1.49 µmol) to CK(ε-NH-TMR)TATG (148 µg, 0.074 µmol) in 25 mM HEPES, pH 7.5, under an atmosphere of N 2 . The product was purified using analytical reverse-phase HPLC. Expected mass (MALDI-TOF), 2,098.19; observed mass, 2,096.31.
Generation of dfTAT by dimerization of CK(TMR)TATG (fTAT)
. dfTAT was formed by dissolving (0.3 mg, 1.5 × 10 −4 mmol) fTAT in aerated phosphate buffer saline (PBS), pH 7.4 (5 ml). Oxygen dissolved in the buffer acted to oxidize the thiol groups on the peptides and form a disulfide bond. The reaction was allowed to react overnight until completion (100% yield according to HPLC analysis). The product was purified using analytical reverse-phase HPLC. Expected mass (MALDI-TOF), 4,080.34; observed mass, 4,084.21. Cloning, overexpression and purification of TAT-Cre, TAT-mCherry, HOXB4 and TAT-HOXB4. The pTriEx-HTNC plasmid encoding His-tagged TAT-NLS-Cre (TAT-Cre) protein was purchased from Addgene. The TAT-Cre gene was then cloned into pTXB1 vector and transformed into Escherichia coli BL21 (DE3) cells (Agilent Technologies). The protein was expressed and purified as described 32 . Briefly, TAT-Cre was expressed with 1 mM IPTG at 37 °C for 3 h. TAT-Cre was then purified to homogeneity using a Ni-NTA resin (Qiagen) and cation-exchange chromatography (HiTrap SP HP) (GE Healthcare).
Generation
pTXB1-TAT-mCherry was obtained by inserting the TAT DNA sequence into the pTXB1-mCherry plasmid. The oligonucleotides with sequences 5′-TAT GGG TCG TAA AAA ACG TCG TCA GCG TCG TCG TGG TCA-3′ and 3′-ACC CAG CAT TTT TTG CAG CAG TCG CAG CAG CAC CAG TAT-5′ (Integrated DNA Technologies) coding for the TAT sequence, which contain NdeI sites, were annealed to generate dsDNA. The pTXB1-mCherry plasmid was cut with NdeI (New England Biolabs) and ligated with TAT dsDNA. The pTXB1-TAT-mCherry plasmid was transformed into BL21 (DE3) cells, and protein expression was induced with 1 mM IPTG at 16 °C for 24 h. Cells were harvested and resuspended in lysis buffer containing 20 mM Tris-Cl (pH 7.5) and 200 mM NaCl. After cell lysis by sonication and high-speed centrifugation at 15,000 r.p.m. (rotor radius: 23 cm) for 1 h, the soluble fraction was applied to chitin resin (New England Biolabs) pre-equilibrated with lysis buffer and incubated overnight at 4 °C (the protein contains a C-terminal intein-chitin binding domain purification tag). The resin was washed with ten column volumes of lysis buffer. The protein was cleaved from the resin by incubating the beads with 1 column volume of cleavage buffer supplemented with 100 mM 2-mercaptoethanesulfonic acid and for 24 h at 4 °C. The protein was further purified using cationexchange chromatography.
EGFP was cloned, expressed and purified as previously described 33 . The double-mutant EGFP (dmEGFP) was obtained by introducing the mutations (C49S, C71V) in the EGFP plasmid using site-directed mutagenesis. Because dmEGFP does not contain any Cys residue, this protein is unable to form a disulfide npg bond with fTAT. In all assays, results obtained with EGFP were similar to those obtained with dmEGFP. In the text, both EGFP and dmEGFP are therefore referred to as EGFP for simplicity.
The pTAT-HA-HOXB4 vector was generously provided by G. Sauvageau (Montreal University). His 6 -HOXB4 was produced by cloning the HOXB4 gene into pET-28a. Briefly, the HOXB4 cDNA was first amplified from pTAT-HA-HOXB4 by using primers designed to introduce the NdeI and XhoI sites at the 5′ and 3′ ends, respectively (5′-GGC ATT CAT ATG GCT ATG AGT TCT TTT TTG ATC AAC TCA-3′; 5′-GGT CAG TCT CGA GCT AGA GCG CGC GGG G-3′) (IDT). The PCR fragment was then inserted into the corresponding NdeI and XhoI sites of the 6xHis-tag vector, pET-28a. The fidelity of the reading frame was confirmed by sequencing. The procedure for the purification of both TAT-HOXB4 and HOXB4 is similar and has been previously described 25 . Briefly, BL21 (DE3) cells were transformed with either pTAT-HA-HOXB4 or pET28a-HOXB4 and induced at 37 °C for 5 h with 1 mM IPTG. The pelleted cells were lysed by sonication in buffer A (8 M urea, 20 mM HEPES, 200 mM NaCl, pH 8.0). Lysates, which were obtained via high-speed centrifugation (14,000 r.p.m., 30 min at 22 °C), were then adjusted to 10 mM imidazole and incubated with Ni-NTA agarose beads for 60 min at room temperature. The nickel beads were then washed with buffer A containing 20 mM and 40 mM imidazole to eliminate the presence of any nonspecific products, and bound proteins were subsequently eluted with 100 mM and 250 mM imidazole in buffer A. Eluates from both concentrations of imidazole containing the proteins of interest (i.e., TAT-HOXB4 or HOXB4) were loaded on a HiTrap SP HP column at 4 °C in buffer B (4 M urea, 20 mM HEPES, 50 mM NaCl, pH 6.5) and eluted on the FPLC in a single-step at 4 °C with buffer C (20 mM HEPES, 1 M NaCl, pH 8.0). Both proteins were immediately desalted by diluting with 20 mM HEPES (pH 8.0) and concentrated using centrifugal filter units with 10K MWCO (EMD Millipore), divided into aliquots and flash frozen at -80 °C. Protein concentrations were determined using the Bradford protein assay (Bio-Rad). were grown in Dulbecco's minimum essential medium (DMEM) (Fisher) supplemented with 10% fetal bovine serum (FBS) (Fisher) and 1× penicillin/streptomycin (P/S) (Fisher) and kept at 37 °C in a humidified atmosphere containing 5% CO 2 . Intestinal porcine epithelial cells (IPEC-1, obtained from G. Wu, Texas A&M University) were cultured in growth medium containing DMEM, 10% FBS, insulin (5 µg/ml; Sigma), hydrocortisone (1 µg/ml; Sigma), EGF (5 ng/ml; BD Biosciences) and 1× P/S and kept at 37 °C in a humidified atmosphere containing 5% CO 2 (ref. 37 ). Cultures were tested for Mycoplasma contamination using the PCR Mycoplasma Test Kit II (PromoKine). HeLa cells were profiled using STR, by ATCC before purchase, but other cell lines were not.
Delivery of peptides inside live cells.
Cells were seeded in eightwell dishes so that the cells were 80-90% confluent after 48 h.
Each well was washed three times with PBS and Leibovitz's L-15 medium that did not contain the amino acid cysteine (nonreducing L-15, nrL-15). The medium (nrL-15) used for incubation lacks cysteine to avoid reduction of the disulfide bond of dfTAT. Cells were then incubated with different concentrations of the acfTAT, fTAT, dfTAT or nrdfTAT at 37 °C for 5-60 min. Cells were washed three times with PBS and nrL-15 and placed on an inverted epifluorescence microscope (Model IX81, Olympus) equipped with a heating stage maintained at 37 °C. Images were collected using a Rolera-MGI Plus back-illuminated electron-multiplying chargecoupled device (EMCCD) camera (Qimaging). Images were acquired using bright-field imaging and three standard fluorescence filter sets: CFP (excitation (Ex) = 436 ± 10 nm/emission (Em) = 480 ± 20 nm), RFP (Ex = 560 ± 20 nm/Em = 630 ± 35 nm) and FITC (Ex = 488 ± 10 nm/Em = 520 ± 20 nm). The fluorescence intensities of different cells were measured with the SlideBook 4.2 software (Olympus), and the average fluorescence intensity was determined for each condition. We have previously reported that cell-penetrating peptides labeled with fluorophores such as TMR can photosensitize membranes and cause endosomal leakage upon light irradiation 19, 27 . To minimize the role played by light irradiation in the activities reported herein, we performed all delivery experiments under conditions of minimal light irradiation (dark room with dim red light). When fluorescence imaging was required, probes (for example, Snap-Surface 488 and EGFP) were imaged before dfTAT images were acquired. dfTAT was also excited for only a maximum of 300 ms. In contrast, the light dose required to observe light-induced endosomal leakage was typically 10-to 20-fold greater than that used for imaging. For experiments performed with Cre and HOXB4, cells were not imaged and not exposed to light during delivery (cells incubated with HOXB4 were never exposed to light, and cells incubated with Cre were imaged 12 h after incubation).
Delivery of peptides and proteins inside live cells by coincubation with dfTAT.
HeLa, HDF and Neuro-2a cells were seeded in eight-well dishes, grown and washed as described in the prior section. Cells were then co-incubated with 5 µM delivery peptide and with the cargo at the corresponding concentration for 1 h at 37 °C. Cells were washed three times with PBS and nrL-15 and placed on the microscope. Images were acquired as described before. For transfection and expression of Snap-H2B and TagCFP-mito, plasmids were mixed with Lipofectamine 2000 reagent in opti-MEM medium and incubated at room temperature for 30 min. The DNA complex was added to previously seeded HeLa cells (80% confluent) on an eight-well dish, and cells were kept at 37 °C for 24 h. After 24 h, the wells were washed three times with PBS and nrL-15 before performing the delivery experiments using the Snap-Surface 488 or FITC-anti-ATP5A (Abcam ab119688). The Snap-Surface 488 fluorescence is known to be quenched (80%) before reacting with the Snap fusion tag 20 . Consequently, we considered the signal of Snap-Surface 488 to be 80% quenched when the molecule is trapped inside endosomes or distributed in the cytosol of cells, but fully fluorescent when localized in the nucleus of cells (where it reacts with Snap-H2B). To estimate the amount of Snap-Surface 488 that escapes from endosomes after dfTAT-mediated delivery, we analyzed the Snap-Surface 488 fluorescence signal obtained after imaging using the SlideBook software. The total signal intensity of the cytoplasmic npg
